DISTRICT OF COLUMBIA
Alpharma Agrees to $42.5 Million Settlement of False Claims Act Allegations
On March 16, 2010, the DOJ announced that U.S.-based pharmaceutical manufacturer Alpharma Inc., now a wholly owned subsidiary of King Pharmaceuticals, Inc, the Bristol, TN-based corporation, has agreed to pay $42.5 million as part of a settlement of alleged False Claims Act violations tied to marketing efforts for Kadian,
This premium content is locked for Business Crimes Bulletin subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN Business Crimes Bulletin
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.